Pacs Group Inc

Pacs Group Inc (PACS) Stock Analysis

$42.750

-1.441 (-3.37%)At close

Loading chart…
High
44.610
Open
44.340
VWAP
43.37
Vol
498.83K
Mkt Cap
Low
42.750
Amount
21.63M
EV/EBITDA, TTM
18.09

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services.

pacs.com

AI analysis of Pacs Group Inc (PACS)

buy

Pacs Group Inc is a good buy right now due to its strong recent earnings report, which showed a revenue increase to $1.43 billion, a 9.1% year-over-year growth, and an adjusted EBITDA of $166.8 million, reflecting a 25% improvement. Additionally, the forward P/E ratio of 17.92 suggests the stock is reasonably valued compared to its growth potential, and analysts have set a price target as high as $62, indicating a potential upside of 45% from the current price of $42.75. The main risk is the RSI of 27.52, indicating the stock is currently oversold, which could lead to further short-term volatility.

Valuation Metrics

The current forward P/E ratio for Pacs Group Inc (PACS) is 17.92, compared to its 5-year average forward P/E of 12.76.

Forward P/E

Fair
5Y Average P/E
12.76
Current P/E
17.92
Overvalued
18.82
Undervalued
6.70

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
5.70
Current EV/EBITDA
18.09
Overvalued
32.94
Undervalued
-21.55

Forward P/S

Fair
5Y Average P/S
0.81
Current P/S
1.10
Overvalued
1.17
Undervalued
0.45

Whales holding PACS

C

Cohen & Steers Capital Management, Inc.

+ HoldingPACS

+2.94%

3M Return

Events Timeline

2026-08-04 (ET)

17:00:00

Company Raises 2026 Revenue Outlook to $5.75B-$5.85B

17:00:00

Company Reports Q2 Revenue of $1.43B, Exceeding Expectations

2026-05-12 (ET)

12:10:00

Pacs Group Stock Rises 20.5% to $38.44

10:10:00

Pacs Group Stock Rises 24.1% to $39.60

2026-05-11 (ET)

19:40:00

Energy and Basic Materials Propel S&P 500 to Record Highs

News

PACS FAQ — answered by Alphio AI

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services. It operates in the Healthcare sector.

Pacs Group Inc is a good buy right now due to its strong recent earnings report, which showed a revenue increase to $1.43 billion, a 9.1% year-over-year growth, and an adjusted EBITDA of $166.8 million, reflecting a 25% improvement. Additionally, the forward P/E ratio of 17.92 suggests the stock is reasonably valued compared to its growth potential, and analysts have set a price target as high as $62, indicating a potential upside of 45% from the current price of $42.75. The main risk is the RSI of 27.52, indicating the stock is currently oversold, which could lead to further short-term volatility.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started